Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 15 | SFEBES2008 | Next issue

Society for Endocrinology BES 2008

Clinical Management Workshops

Managing the obese

ea0015s50 | Managing the obese | SFEBES2008

Managing the obese patients: lifestyle intervention and prescriptive exercise

Andrews Rob

Overeating and decreased activity are the fundamental problems underlying the development of obesity, thus any therapy aimed at helping the obese patient must have a dietary and exercise component.In general three forms of lifestyle interventions are used; exercise, diet and behavioural therapy. Exercise alone produces an average weight loss of 1.8 kg (0–4 kg) with a higher intensity of exercise leading to a greater weight loss. Diastolic blood pres...

ea0015s51 | Managing the obese | SFEBES2008

Obesity management: the role of drugs in the 21st Century

Wilding John

The use of drugs for weight loss dates back to the first half of the 20th century. These older agents were mostly amfetamine-derived, centrally acting sympathomimetics, and although effective, their side-effect profile would not be acceptable today. A new generation of drugs, acting on brain serotoninergic pathways was developed in the 1960’s, including fenfluramine and later dexfenfluramine. In the 1990’s, a combination of fenfluramine with an older agent – phe...

ea0015s53 | Managing the obese | SFEBES2008

Managing the obese patient: role of bariatric surgery

Aylwin S

The relentless rise in the prevalence of obesity predicts an exponential increase in the incidence of obesity-related complications. Whereas preventative lifestyle measures must remain the cornerstone of management for the population at large, there remains a growing cohort of patients who remain in the severe obese (BMI>40 kg/m2) category and who suffer from the associated co-morbidities. Medical treatments may be sufficient for lesser degrees of obesity, for t...